Tetrilimus is an advanced everolimus-eluting cobalt-chromium coronary stent system developed by Sahajanand Medical Technologies (SMT). Featuring an innovative Tetrinium platform, ultrathin stent struts, and a unique biodegradable polymer coating, Tetrilimus is designed to provide enhanced flexibility, deliverability, and structural integrity. Its biphasic drug-release technology supports controlled everolimus delivery while maintaining coating integrity and promoting vascular healing.